Journal of clinical oncology : official journal of the American Society of Clinical Oncology

• Latest
• Best
• Search…

• J. Clin. Oncol. · Sep 2015

  Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue Biopsies.

  To evaluate the prognostic impact of cell-of-origin (COO) subgroups, assigned using the recently described gene expression-based Lymph2Cx assay in comparison with International Prognostic Index (IPI) score and MYC/BCL2 coexpression status (dual expressers). ⋯ Assignment of DLBCL COO by the Lymph2Cx assay using FFPET biopsies identifies patient groups with significantly different outcomes after R-CHOP, independent of IPI score and MYC/BCL2 dual expression.

  read on… or just mark as read…

• J. Clin. Oncol. · Sep 2015

  Comment Letter

  Reply to C. Le Péchoux et al and B.S. Gill et al.

  no abstract available

  explore further… or not…

• J. Clin. Oncol. · Sep 2015

  Comment Letter

  Older Men With Locally Advanced Prostate Cancer: To Treat or Not to Treat?

  no abstract available

  read more… or just mark as read…

• J. Clin. Oncol. · Sep 2015

  Comment Letter

  Does Radiotherapy Plus Androgen-Deprivation Therapy Represent the Best Treatment Approach in Elderly Patients With Locally Advanced Prostate Cancer?

  no abstract available

  expand abstract… or not…

• J. Clin. Oncol. · Sep 2015

  Editorial Comment

  Can We Predict Bevacizumab Responders in Patients With Glioblastoma?

  no abstract available

  read on… or not…